A phase IV, open-label assessment of the treatment of actinic keratoses with diclofenac sodium 3% topical gel

被引：1
|
作者：
Rigel, DS
Swanson, N
Wolf, J
Smith, S
机构：
[1] NYU, Med Ctr, New York, NY 10016 USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.10.421
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P479
引用
收藏
页码：P124 / P124
页数：1
相关论文
共 50 条
  • [41] Response to "Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0.015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp'
    Malvehy, J.
    Puig, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (03) : 812 - 813
  • [42] An open-label phase 2 clinical trial of topical remetinostat gel for basal cell carcinoma
    Urman, N.
    Eichstadt, S.
    Do, H.
    Mirza, A. N.
    Li, S.
    Oro, A.
    Aasi, S.
    Sarin, K. Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S171 - S171
  • [43] Three-day topical treatment with ingenol mebutate gel, 0.015% for actinic keratoses on the face
    Berman, B.
    Marmur, E.
    Melgaard, A.
    Larsson, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 109 - 109
  • [44] Genetically determined susceptibility to COX-2 inhibitors - a report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratoses
    Patel, M. J.
    Ulrich, C.
    Forschner, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 : 57 - 61
  • [45] Topical ketanserin gel for anal fissure: An open-label, prospective study
    M. M. Zielanowski
    Advances in Therapy, 2000, 17 : 27 - 31
  • [46] Topical ketanserin gel for anal fissure: An open-label, prospective study
    Zielanowski, MM
    ADVANCES IN THERAPY, 2000, 17 (01) : 27 - 31
  • [47] Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis
    Kose, Osman
    Koc, Erol
    Erbil, A. Hakan
    Caliskan, Ercan
    Kurumlu, Zafer
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (03) : 159 - 163
  • [48] Successful management of disseminated superficial actinic porokeratosis with diclofenac sodium 3% gel
    Otero-Rivas, Maria-Mercedes
    Rodriguez-Lojo, Romina
    Castineiras-Mato, Iria-Margarita
    Lueiro-Vilarino, Mercedes
    Juarez-Casado, Yolanda
    Fernandez-Diaz, Maria-Luisa
    DERMATOLOGIC THERAPY, 2017, 30 (03)
  • [49] Combination therapy with imiquimod and 5-fluorouracil cream for the treatment of actinic keratoses, a prospective open-label nonrandomized uncontrolled pilot trial
    Regester, Richard Maxwell
    Cannella, Amy C.
    Hirz, Julianna
    Sayles, Brian
    Schlange, Stacie
    Rau, Amy
    Sayles, Harlan R.
    Griess, Anthony J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (06) : 1247 - 1249
  • [50] Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study
    Stough, Dow
    Bucko, Alicia D.
    Vamvakias, George
    Rafal, Elyse S.
    Davis, Steven A.
    CUTIS, 2010, 85 (05): : 267 - 273
12345